---
document_datetime: 2023-09-21 19:18:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/repaglinide-teva-epar-all-authorised-presentations_en.pdf
document_name: repaglinide-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7016127
conversion_datetime: 2025-12-28 00:33:04.863885
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name             | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging         | Package size   |
|-----------------|------------------|------------|-----------------------|---------------------------|-------------------|----------------|
| EU/1/09/530/001 | Repaglinide Teva | 0.5 mg     | Tablet                | Oral use                  | blister (alu/alu) | 30 tablets     |
| EU/1/09/530/002 | Repaglinide Teva | 0.5 mg     | Tablet                | Oral use                  | blister (alu/alu) | 90 tablets     |
| EU/1/09/530/003 | Repaglinide Teva | 0.5 mg     | Tablet                | Oral use                  | blister (alu/alu) | 120 tablets    |
| EU/1/09/530/004 | Repaglinide Teva | 0.5 mg     | Tablet                | Oral use                  | blister (alu/alu) | 270 tablets    |
| EU/1/09/530/005 | Repaglinide Teva | 0.5 mg     | Tablet                | Oral use                  | blister (alu/alu) | 360 tablets    |
| EU/1/09/530/006 | Repaglinide Teva | 1 mg       | Tablet                | Oral use                  | blister (alu/alu) | 30 tablets     |
| EU/1/09/530/007 | Repaglinide Teva | 1 mg       | Tablet                | Oral use                  | blister (alu/alu) | 90 tablets     |
| EU/1/09/530/008 | Repaglinide Teva | 1 mg       | Tablet                | Oral use                  | blister (alu/alu) | 120 tablets    |
| EU/1/09/530/009 | Repaglinide Teva | 1 mg       | Tablet                | Oral use                  | blister (alu/alu) | 270 tablets    |
| EU/1/09/530/010 | Repaglinide Teva | 1 mg       | Tablet                | Oral use                  | blister (alu/alu) | 360 tablets    |
| EU/1/09/530/011 | Repaglinide Teva | 2 mg       | Tablet                | Oral use                  | blister (alu/alu) | 30 tablets     |
| EU/1/09/530/012 | Repaglinide Teva | 2 mg       | Tablet                | Oral use                  | blister (alu/alu) | 90 tablets     |
| EU/1/09/530/013 | Repaglinide Teva | 2 mg       | Tablet                | Oral use                  | blister (alu/alu) | 120 tablets    |
| EU/1/09/530/014 | Repaglinide Teva | 2 mg       | Tablet                | Oral use                  | blister (alu/alu) | 270 tablets    |
| EU/1/09/530/015 | Repaglinide Teva | 2 mg       | Tablet                | Oral use                  | blister (alu/alu) | 360 tablets    |